

Most Read This Week
- Neoadjuvant–Adjuvant vs Adjuvant-Only Pembrolizumab for Advanced Melanoma
- Efficacy of Paroxetine in the Treatment of Patients With Refractory Erythema of Rosacea
- Nicotinamide for Skin Cancer Chemoprevention in Transplant Recipients
- Role of Topical Nasal Decongestant Oxymetazoline as a Novel Therapeutic Option for Post-Acne Erythema
- Awareness of Dermatologists Regarding Association Between Hydrochlorothiazide Use and Nonmelanoma Skin Cancer
Recently Updated
- AAD: Risk for Skin Cancer Higher for Adults With Atopic Dermatitis
- AAD 2023: Upadacitinib Provides Early, Long-Lasting Relief for Atopic Dermatitis
- AAD 2023: Dupilumab Tied to Significant Improvements in Atopic Hand and Foot Dermatitis
- AAD 2023: Baricitinib Shows Long-Term Efficacy for Severe Alopecia
- AAD 2023: Tapinarof Cream 1 Percent Shows Clinically Meaningful Efficacy for Plaque Psoriasis